Abstract LB167: A powerful discovery platform for the generation of high affinity and specificity TCR-like antibodies for immunotherapies in solid tumor

Citation Format: Stephanie Jungmichel, Fabian Scheifele, Anna Sobieraj, Philip Knobel, Philipp Richle, Hannes Merten, Thomas Schleier, Melissa Vrohlings, Christian Leisner, Leonardo Borras. A powerful discovery platform for the generation of high affinity and specificity TCR-like antibodies for immunotherapies in solid tumor [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr LB167.